50
Onco
l
Vol 7
l
Nr 3
l
2013
AGENDA
ONA073N
Nationale vergaderingen
UZ Gent
Oefeningen in evidence based medicine
12.30u-13.30u UZ Gent, bibliotheek afdeling gastro-
enterologie 1K12E
28/06/2013
Verlaagt het gebruik van PPI het risico op
het ontwikkelen van adenocarcinoom ter
hoogte van een Barrett? (K. Gorleer)
UZ Brussel
Seminars in oncology
16.00u-17.00u UZ Brussel, Oncologisch centrum, seminar
room prof. W. Smets, Laarbeeklaan 101, 1090 Brussel
Info: prof. M. De Ridder, tel 02/4776147
25/06/2013
Clinical trials: new proposals & update
Belgian Society of Medical Oncology
16
th
Post-ASCO Meeting
29/06/2013
08.30u-13.00u Château du Lac,
Avenue du Lac, 1332 Genval
08.30
Welcome with coffee & croissants
(M. Dicato & J.B. Vermorken)
09.00
Lung Cancer (J. Vansteenkiste, KUL)
09.25
Gastro-intestinal cancer (M. Peeters, UZA)
09.50
Uro-genital cancer (B. Tombal, UCL)
10.10
ASCO Highlights (F. Ries, CHU Luxembourg)
10.30 Break
11.00
Bench to bedside (J. De Grève, VUB)
11.15
Head & neck cancer (J.B. Vermorken)
11.40
Geriatric oncology (M.SM. Aapro, Geneva)
12.00
Breast cancer (M. Piccart, ULB)
12.30
Conclusions & reception
Kankerplan Plan Cancer
Congres dysfagie
26/09/2013
09.00u-17.00u ALM Antwerpen,
Filip Williotstraat 9, 2600 Berchem
Registratie: www.uza.be/dysfagie
Dysphagia in head and neck cancer: cause & cure
27/09/2013
09.00u-17.00u UMC Sint-Pieter campus
César De Paepe, Cellebroersstraat 11-13, 1000 Brussel
Registratie: www.uza.be/head-neck-cancer
Markers in Cancer
A joint meeting by ASCO, EORTC and NCI
7 - 9 November 2013
Square Meeting Centre - Brussels, Belgium
www.markersincancer.eu
This year, Markers in Cancer will focus on the relevance and the feasibility of implementing emerging
technologies in clinical practice. Next generation sequencing and high throughput screening technologies
are revolutionizing our current molecular understanding of cancer. Molecular tumor profiles can now be
established at affordable cost within a timeframe compatible with clinical practice, and soon biomarker-
based patient selection will move to the forefront of effective cancer treatment for the majority of
patients. You will learn about current biomarker research and what is necessary to turn next generation
biomarkers into reliable diagnostics. A Diagnostic Development Tutorial will be held prior to the Main
Meeting (5 - 7 November 2013) on Molecular Markers in Cancer in order to address issues critical to
understanding the advances, development, limitations, and validation of molecular markers.
S A V E T H E D A T E
Registration is NOW open
ECOS application closes on 17 June
Abstract submission closes on 20 June
Be ready for the next generation of cancer treatments !
©
w
w
w
.
a
t
o
m
i
u
m
.
b
e
-
S
A
B
A
M
2
0
1
3
-
A
m
a
n
i
to
2-MarkersCancer_EU2013_OncoHemato.indd 1
24-May-13 8:24:42 AM
Uw congres, seminarie, symposium of
bijscholingsactiviteit ook in Onco? Mail het
programma twee maanden op voorhand naar
onco@rmnet.be.